A Phase 2, Double-blind Study to Evaluate Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult

NCT03784885 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

345

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Infection

Interventions

BIOLOGICAL: AD07010
BIOLOGICAL: Inactivated trivalent influenza vaccine

Sponsor

Advagene Biopharma Co. Ltd.